Peptide Regulatory Status Tracker
The Peptide Regulatory Status Tracker provides a current overview of FDA approval status, compounding legality, and DEA scheduling classification for peptides commonly used in therapeutic settings. This resource helps patients, providers, and pharmacists understand the legal landscape for peptide therapies, which varies by substance and jurisdiction. Regulatory status is reviewed monthly and updated whenever federal or state actions affect peptide availability.
Showing 49 peptides with regulatory data.
| Peptide | US Status | Rx Required | Last Verified |
|---|---|---|---|
| Liraglutide details → | FDA Approved | Yes | |
| Oxytocin details → | FDA Approved | Yes | |
| Pentosan Polysulfate details → | FDA Approved | Yes | |
| PT-141 details → | FDA Approved | Yes | |
| Semaglutide details → | FDA Approved | Yes | |
| SS-31 details → | FDA Approved | Yes | |
| Tesamorelin details → | FDA Approved | Yes | |
| Tirzepatide details → | FDA Approved | Yes | |
| 5-Amino-1MQ details → | Compoundable (503A) | Yes | |
| Cerebrolysin details → | Compoundable (503A) | Yes | |
| Collagen Peptides details → | Compoundable (503A) | Yes | |
| Danuglipron details → | Compoundable (503A) | Yes | |
| GHRP-2 details → | Compoundable (503A) | Yes | |
| GHRP-6 details → | Compoundable (503A) | Yes | |
| Hexarelin details → | Compoundable (503A) | Yes | |
| VIP details → | Compoundable (503A) | Yes | |
| AOD-9604 details → | Pending Reclassification | Yes | |
| BPC-157 details → | Pending Reclassification | Yes | |
| CJC-1295 details → | Pending Reclassification | Yes | |
| GHK-Cu details → | Pending Reclassification | Yes | |
| Ipamorelin details → | Pending Reclassification | Yes | |
| KPV details → | Pending Reclassification | Yes | |
| MOTS-c details → | Pending Reclassification | Yes | |
| Selank details → | Pending Reclassification | Yes | |
| Semax details → | Pending Reclassification | Yes | |
| Sermorelin details → | Pending Reclassification | Yes | |
| TB-500 details → | Pending Reclassification | Yes | |
| Thymosin Alpha-1 details → | Pending Reclassification | Yes | |
| Argireline details → | Gray Area | — | |
| Matrixyl (Palmitoyl Pentapeptide) details → | Gray Area | — | |
| Snap-8 details → | Gray Area | — | |
| AHK-Cu details → | Research Only | — | |
| CagriSema details → | Research Only | — | |
| Dihexa details → | Research Only | — | |
| DSIP details → | Research Only | — | |
| Ecnoglutide details → | Research Only | — | |
| Humanin details → | Research Only | — | |
| LL-37 details → | Research Only | — | |
| Mazdutide details → | Research Only | — | |
| Melanotan II details → | Research Only | — | |
| MK-677 details → | Research Only | — | |
| Orforglipron details → | Research Only | — | |
| Pemvidutide details → | Research Only | — | |
| Pinealon details → | Research Only | — | |
| Retatrutide details → | Research Only | — | |
| Survodutide details → | Research Only | — | |
| Thymalin details → | Research Only | — | |
| Thymosin Beta-4 details → | Research Only | — | |
| Vesilute details → | Research Only | — |
Frequently Asked Questions
What does FDA approval mean for a peptide?
FDA approval means the peptide has completed clinical trials demonstrating safety and efficacy for specific medical indications. Approved peptides can be prescribed by physicians and dispensed by pharmacies.
Can non-FDA-approved peptides be legally prescribed?
In many cases, yes. Compounding pharmacies can legally prepare non-FDA-approved peptides under state pharmacy board regulations, particularly under section 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
How often is the regulatory status updated?
We review regulatory status monthly and update this page whenever FDA, DEA, or state pharmacy board actions affect peptide availability or legal status.